Neuromyelitis Optica Archives - NORD (National Organization for Rare Disorders)

Scroll
To Top

donate

Advanced Search

Archives for: January 18th, 2018

Early Diagnosis: Perspectives from NORD Student Chapter Leader, Harjot Randhawa

Written by Christina Jensen on January 18, 2018

During the 2017 Rare Diseases & Orphan Products Breakthrough Summit over 700 individuals from the rare disease community gathered to advance the dialogue in rare diseases. NORD was pleased to have a large group of student chapter leaders involved with the event in 2017. One leader,… Read More

NORD Announces Honorees for the 2017 Rare Impact Awards

Written by Jennifer Huron on March 15, 2017

Washington, D.C., March 15, 2017—The National Organization for Rare Disorders (NORD) today announced the people, organizations, and innovators who will be honored at the 2017 Rare Impact Awards on May 18 in Washington, D.C.

The Rare Impact Awards is a… Read More

Tweets From NORD

DEADLINE APPROACHING to apply for 2019 #raredisease research grants from #NORD. There are 11 new funding opportunit… https://t.co/gMbUnpwbYZyesterday
Debbie has helped spearhead the growth of #raredisease advocacy in Texas and driven positive policy change by lobby… https://t.co/MsVya60RHEyesterday
What's the difference between generic & name brand drugs, & how can #biosimilars provide safe treatment options & i… https://t.co/2gRLTZ9TNLyesterday
Check out, Laila, a young woman with #raredisease, HLH, have the experience of a lifetime. #StanleyCup https://t.co/ABscu91t492 days ago

Follow @RareDiseases

Alone we are rare. Together we are strong.®

For Patients and Families

For Clinicians and Researchers

For Patient Organizations

Advocate

Get Involved

Home

About

News

Events

Contact

Careers

Brand Usage Guidelines

Sign Up for NORD News!
For Email Newsletters you can trust.

Follow NORD

Site Map

Website Credits

Privacy

Copyright ©2019 NORD - National Organization for Rare Disorders, Inc. All rights reserved. NORD is a registered 501(c)(3) charity organization. Please note that NORD provides this information for the benefit of the rare disease community. NORD is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.